Breast Ultrasound CME Course with Tom Stavros 2020

Breast Ultrasound CME Course with Tom Stavros - Hot Topics in Advanced Screening and Diagnosis is organized by World Class CME. The symposium is held from Jan 17 - 19, 2020 at The Westin Riverwalk, San Antonio, San Antonio, Texas, United States of America.

Target Audience:
Radiologists and radiology residents/fellows, breast surgeons, sonographers, radiology technologists and advanced practitioners who seek to learn, in-depth, how to use breast ultrasound in a clinical practice setting for diagnosis, screening and staging of breast disease.

Accreditation:
• 20.75 AMA PRA Category 1 Credits™
These credits can be used toward ABR MOC Part 2 requirements

• 6.0 SAMs Credits
These credits can be used toward ABR MOC Part 2 SA-CME requirements

ASRT approved for 21.5 Category A CE Credits for Sonographers and Technologists:
• Friday AM Session - 4.75
• Friday PM Session - 4.25
• Saturday AM Session - 4.75
• Saturday PM Session - 2.5
• Sunday Session - 5.25

Description:
“Welcome to San Antonio and the Hot Topics in Advanced Screening and Diagnosis. This session will emphasize a new classification system on breast cancer and will focus non-mass ultrasound findings, an analysis of causes of false-negative BI-RADS 3 classifications, and new ways of classifying breast nodules that can help objectively assign BI-RADS 4 subcategories and improve ultrasound’s ability to serve as a biomarker. I will lead interactive case readings with an audience response system, and we have time set aside for questions and answers.” - Tom Stavros

Course Objectives:
Upon completion of this conference, the participant will be able to:
• Understand the differences in pre-test probabilities and guidelines for interpretation between diagnostic, supplemental screening, and MRI-directed indications for breast ultrasound and how that affects management and interpretation
• Select the most appropriate ultrasound equipment, machine settings, and scan techniques for better diagnostic evaluations
• Understand the anatomic and histopathologic basis for ultrasound appearances
• Correlate areas of clinical, mammographic, screening ultrasound, or MRI concern with ultrasound, and understand the anatomic and histopathologic basis for ultrasound appearances
• Identify both mass and non-mass sonographic findings that are suspicious for malignancy, how to use them in classifying breast masses and in staging breast cancers
• Understand a new way of classifying ultrasound features that can aid in more objectively using and achieving ACR PPV benchmarks for BI-RADS 4 subcategories and function better as biomarkers than prior methods of classification
• Identify the few truly suspicious complex cystic and solid masses that require biopsy and distinguish them from the myriad of non-simple breast cysts that are definitively benign
• Understand the roles of ultrasound and galactography in diagnosis and guiding biopsy in patients presenting with nipple discharge
• Recognize the range of normal and abnormal appearances for breast implants
• Enhance ultrasound-guided breast biopsy and interventional skills
• Utilize the new classification system of breast malignancies that is based upon site of origin – within ducts, within TDLUs, or within peri-ductal mesenchymal tissues for better correlation with prognosis
• Understand the appropriate role for supplemental bilateral whole breast ultrasound as well as other ancillary imaging modalities in women with negative but dense mammograms
• Improve detection and correct classification of small invasive breast cancers while minimizing false positive 
ultrasound examinations
• Learn how to overcome the headwinds in establishing a supplemental whole breast ultrasound program in women with dense breasts
• Learn to distinguish normal from abnormal regional lymph nodes, determine whether abnormal nodes are more likely metastatic or reactive, and how Z0011 might affect current management of nodes
• Become familiar with a new functional imaging platform called Opto-acoustic Imaging
• Understand the benefits of integrating this new technology into breast ultrasound, so that the radiologist can significantly increase specificity when analyzing a mass, and potentially obviate the need for many breast biopsies.